Eknath Kole

Employment

• University Department of Pharmaceutical Sciences, MGM University Chhatrapati Sambhajinagar Research Scholar
  2025 - Present
• JSPM's Jayawantrao Sawant Institute of Pharmacy Assistant Professor
  2018 - 2021
• R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur Assistant Professor
  2017 - 2018

Education

• University Institute of Chemical Technology, KNC North Maharashtra University, Jalgaon PhD
  2020 - 2025
• National Institute of Pharmaceutical Education and Research M.S. Pharm
  2015 - 2017
• Sant Gadge Baba Amravati University Bachelor of Pharmacy (B. Pharm)
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (21)

• Spray-dried inhalable nano-embedded microparticles of isoniazid and pyridoxine hydrochloride for pulmonary tuberculosis
  RSC Pharmaceutics 2026 DOI: 10.1039/D5PM00118H
  +Save
• Next-generation nanomedicine for MDR-TB: PROTAC nanocarriers, granuloma penetration, and AI-driven design
  Journal of Drug Delivery Science and Technology 2026 DOI: 10.1016/j.jddst.2026.108660
  +Save
• Gelatin-based electrospun materials for drug delivery system
  Electrospun Biomaterials for Tissue Engineering and Drug Delivery Applications 2025 DOI: 10.1016/B978-0-443-29066-4.00009-3
  +Save
• Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19
  Critical Reviews in Therapeutic Drug Carrier Systems 2025 DOI: 10.1615/CRITREVTHERDRUGCARRIERSYST.2025053265
  +Save
• Development and characterisation of lyophilised ethambutol-loaded polymeric nanoparticles
  Journal of Applied Pharmaceutical Research 2025 DOI: 10.69857/JOAPR.V13I2.1093
  +Save
• Revealing the potential of nano spray drying for effective delivery of pharmaceuticals and biologicals
  Drying Technology 2025 DOI: 10.1080/07373937.2024.2437691
  +Save
• Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review
  Drying Technology 2025 DOI: 10.1080/07373937.2024.2437690
  +Save
• Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer
  Current Drug Delivery 2025 DOI: 10.2174/0115672018278617231207051907
  +Save
• Peptide-Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress
  2025 DOI: 10.20944/preprints202503.1521.v1
  +Save
• Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress
  Bioengineering 2025 DOI: 10.3390/bioengineering12050481
  +Save